Significantly better change scores seen in Roland-Morris Disability Questionnaire at six and 12 months with acupuncture ...

Altaviva is a minimally invasive implantable neuromodulation device that is inserted into the ankle and delivers electrical stimulation to the tibial nerve.

The approval was based on the TRuE-AD3 trial, which evaluated the safety and efficacy of ruxolitinib in pediatric patients aged 2 to 11 years with atopic dermatitis.

Associations were largely or fully attenuated using designs other than accounting for measured confounders and in sibling comparisons.

HealthDay News — For patients treated with nicotinamide, the risk for skin cancer is reduced, especially when initiated after a first skin cancer, according to a study published online September 17 in ...

Vaccination against measles, mumps, rubella, and varicella is typically administered in 2 doses: the first between 12 to 15 months and the second at 4 to 6 years.

Second study shows 7.2mg semaglutide leads to greater reductions in mean body weight for those with obesity, T2D.

New device approved to prevent intrauterine adhesions; oral GLP-1 receptor agonists assessed in head to head trial; nasal spray formulation of bumetanide gains approval; Capvaxive elicits immune ...

Modeling study shows decrease in prevalence of both obesity and stroke under Standard Time, Daylight Saving Time versus current polic.y ...

Airsupra is a pressurized metered dose inhaler containing a combination of albuterol, a SABA, and budesonide, an ICS.

The Womed Leaf consists of a proprietary polymer that is inserted into the uterine cavity immediately after completion of a hysteroscopic adhesiolysis procedure.

The Food and Drug Administration (FDA) has approved Enbumyst ™, a nasal spray formulation of bumetanide, for the treatment of edema associated with congestive heart failure (CHF), and hepatic and ...